Search - tctmd.com

Displaying 841 - 860 of 10338

Sort: Relevancy | Date

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

Individual and Programmatic CTO Development: Lessons Learned the Hard Way

Presenter: James C. Spratt, Simon J. Walsh, Steven P. Marso

October 31, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Presenter: Seung-Jung Park, Leif Thuesen, Davide Capodanno

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Presenter: Tony Das, Koen Deloose, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty VI: Cardiac Implants

Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Presenter: Raj Makkar, Lars Sondergaard, A. Pieter Kappetein

October 31, 2016

Presentation TCT 2016

Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Elizabeth A. Leedom

October 31, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty V: Valcare

Presenter: Ted Feldman, Scott Lim, David Meerkin

October 31, 2016

Presentation TCT 2016

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Presenter: Ran Kornowski, Michel R. Le May, Natalia Pinilla-Echeverri

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington

October 31, 2016

Advertisement

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Individual and Programmatic CTO Development: Lessons Learned the Hard Way

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

ABSORB China Clinical Outcomes at 2 Years

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Trial #3 - The Essentials of ... the LEADERS FREE trial

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

ABSORB II Clinical Outcomes at 3 Years

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Direct Annuloplasty VI: Cardiac Implants

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Direct Annuloplasty V: Valcare

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content